The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Cellular Fatty Acid Metabolism and Cancer
Open accessAbstract
Cancer cells often have characteristic changes in metabolism. Cellular proliferation, a common feature of all cancers, requires fatty acids for synthesis of membranes and signaling molecules. Here, we provide a view of cancer cell metabolism from a lipid perspective, and we summarize evidence that limiting fatty acid availability can control cancer cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, expression of ACLY, a key enzyme in the shift from the TCA cycle to lipid formation that has been shown to cause lipid droplet accumulation42, is significantly higher in LDAM than in microglia without lipid droplets.”
From Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredIn the citing paper
“Fatty acid synthesis is an anabolic process that uses cytosolic citrate to produce acetyl-CoA73.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [73]
In the citing paper
“Next, mitochondrial citrate is transported across the inner mitochondrial membrane via a citrate carrier (CIC or SLC25A1) to support fatty acid synthesis for tumor progression in hypoxia73 (Fig. 4).”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [73]
In the citing paper
“PHD3 is suppressed in cancers that rely on FAO, such as AML and prostate cancer, and elevated in cancers that rely on FAS such as breast and non-small-lung-cell cancer.55–57”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“A better understanding of these metabolic changes has prompted new approaches toward cancer therapy (reviewed in Hsu and Sabatini, 2008; Schulze and Harris, 2012).”
BackgroundATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Flagged first, then by citations
1 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,000
Key Molecules of Fatty Acid Metabolism in Gastric Cancer
Li, C., Zhang, L., Qiu, Z., Deng, W., & Wang, W. (2022) · Biomolecules · doi:10.3390/biom12050706 · Cited by 119
Tang, C., Li, S., Zhang, K., Li, J., Han, Y., Zhan, T., Zhao, Q., Guo, X., & Zhang, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101519 · Cited by 115
FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth
Wei, W., Qin, B., Wen, W., Zhang, B., Luo, H., Wang, Y., Xu, H., Xie, X., Liu, S., Jiang, X. J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01405-8 · Cited by 119
Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment
Wang, J., He, Y., Hu, F., Hu, C., Sun, Y., Yang, K., & Yang, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212223 · Cited by 122
Drury, J., Rychahou, P. G., He, D., Jafari, N., Wang, C., Lee, E. Y., Weiss, H. L., Evers, B. M., & Zaytseva, Y. Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01185 · Cited by 111
Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis
Dasgupta, S., Putluri, N., Long, W., Zhang, B., Wang, J., Kaushik, A., Arnold, J. M., Bhowmik, S. K., Stashi, E., Brennan, C. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76029 · Cited by 112
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism
Verdegem, D., Moens, S., Stapor, P. C., & Carmeliet, P. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-19 · Cited by 117
Li, B., Li, Y., Zhou, H., Xu, Y., Cao, Y., Cheng, C., Peng, J., Li, H., Zhang, L., Su, K., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000553 · Cited by 110
Yang, X., Deng, B., Zhao, W., Guo, Y., Wan, Y., Wu, Z., Su, S., Gu, J., Hu, X., Feng, W., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.09.029 · Cited by 111
Rossi, A., Rigotto, G., Valente, G., Giorgio, V., Basso, E., Filadi, R., & Pizzo, P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.060 · Cited by 109
Research trends in pharmacological modulation of tumor‐associated macrophages
Wang, N., Wang, S., Wang, X., Zheng, Y., Yang, B., Zhang, J., Pan, B., Gao, J., & Wang, Z. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.288 · Cited by 111
Wang, J., Zhang, J., Shi, Y. P., Xu, C., Zhang, C., Wong, Y. K., Lee, Y. M., Krishna, S., He, Y., Lim, T. K., et al. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00156 · Cited by 108
Zhang, F., Liu, H., Duan, M., Wang, G., Zhang, Z., Wang, Y., Qian, Y., Yang, Z., & Jiang, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01304-5 · Cited by 111
D'Amore, S., Vacca, M., Cariello, M., Graziano, G., D'Orazio, A., Salvia, R., Sasso, R. C., Sabbà, C., Palasciano, G., & Moschetta, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.003 · Cited by 107
Obesity and Cancer Progression: Is There a Role of Fatty Acid Metabolism?
Balaban, S., Lee, L. S., Schreuder, M., & Hoy, A. J. (2015) · BioMed Research International · doi:10.1155/2015/274585 · Cited by 107
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
Strickaert, A., Saiselet, M., Dom, G., Deken, X. D., Dumont, J. E., Féron, O., Sonveaux, P., & Maenhaut, C. (2016) · Oncogene · doi:10.1038/onc.2016.411 · Cited by 111
Apocryphal FADS2 activity promotes fatty acid diversification in cancer
Young, R. S. E., Bowman, A. P., Williams, E. D., Tousignant, K. D., Bidgood, C. L., Narreddula, V. R., Gupta, R., Marshall, D. L., Poad, B. L. J., Nelson, C. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108738 · Cited by 109
The Metabolic Landscape of Prostate Cancer
Giunchi, F., Fiorentino, M., & Loda, M. F. (2018) · European Urology Oncology · doi:10.1016/j.euo.2018.06.010 · Cited by 107
Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer
Ji, Z., Shen, Y., Feng, X., Kong, Y., Shao, Y. W., Meng, J., Zhang, X., & Yang, G. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.593017 · Cited by 103
Asleh, K., Dery, V., Taylor, C., Davey, M., Djeungoue‐Petga, M., & Ouellette, R. J. (2023) · Biomarker Research · doi:10.1186/s40364-023-00540-2 · Cited by 117
Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis
Chen, J., Zhao, D., Wang, Y., Liu, M., Zhang, Y., Feng, T., Xiao, C., Huan, S., Miao, R., Xu, L. N., et al. (2024) · Advanced Science · doi:10.1002/advs.202406333 · Cited by 110
Li, L., Che, L., Tharp, K. M., Park, H., Pilo, M. G., Cao, D., Cigliano, A., Latte, G., Xu, Z., Ribback, S., et al. (2016) · Hepatology · doi:10.1002/hep.28508 · Cited by 105
Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy
Guerra, Â. R., Duarte, M. F., & Duarte, I. F. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b04104 · Cited by 102
Cheng, H., Wang, M., Su, J., Li, Y., Jiao, L., Chu, J., Wan, X., Cao, Y., & Li, Q. (2022) · Life · doi:10.3390/life12060784 · Cited by 116
Xu, S., Liu, M., Bai, Y., & Liu, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202009682 · Cited by 104
Quan, J., Cheng, C., Tan, Y., Jiang, N., Liao, C., Liao, W., Cao, Y., & Luo, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69802 · Cited by 103
Cancer stem cells and niches: challenges in immunotherapy resistance
Pan, Y., Yuan, C., Zeng, C., Sun, C., Xia, L., Wang, G., Chen, X., Zhang, B., Liu, J., & Ding, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02265-2 · Cited by 117
Ma, Y., Zha, J., Yang, X., Li, Q., Zhang, Q., Yin, A., Beharry, Z. M., Huang, H., Huang, J., Bartlett, M. G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01667-y · Cited by 109
Qiu, P., Zhou, Y., Oyang, L., Wu, N., Tang, Y., Su, M., Luo, X., Wang, Y., Sheng, X., Ma, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.010 · Cited by 109
Zhang, Y., & Ertl, H. C. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00032 · Cited by 102
Central Role of Metabolism in Endothelial Cell Function and Vascular Disease
Bierhansl, L., Conradi, L., Treps, L., Dewerchin, M. A., & Carmeliet, P. (2017) · Physiology · doi:10.1152/physiol.00031.2016 · Cited by 107
Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma
Caragher, S. P., Shireman, J. M., Huang, M., Miska, J. M., Atashi, F., Baisiwala, S., Park, C. H., Saathoff, M. R., Warnke, L., Xiao, T., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1589-18.2018 · Cited by 101
Fan, Y., Zhou, X. Y., Xia, T., Chen, Z., Li, J., Liu, Q., Alolga, R. N., Chen, Y., Lai, M., Li, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7155 · Cited by 104
Jia, Z., Zhang, H., Ong, C. N., Patra, A., Lu, Y., Lim, C. T., & Venkatesan, T. (2018) · ACS Omega · doi:10.1021/acsomega.7b02035 · Cited by 100
Digging deeper through glucose metabolism and its regulators in cancer and metastasis
Ghanavat, M., Shahrouzian, M., Zayeri, Z. D., Banihashemi, S., Kazemi, S. M., & Saki, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118603 · Cited by 100
Zhang, J., Song, Y., Shi, Q., & Fu, L. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0830-0 · Cited by 100
Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
Park, S., & Hall, M. N. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01415-2 · Cited by 108
Tumor-Induced Hyperlipidemia Contributes to Tumor Growth
Huang, J., Li, L., Lian, J., Schauer, S., Vesely, P. W., Kratky, D., Höefler, G., & Lehner, R. S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.020 · Cited by 103
Luo, J., Hong, Y. K., Lü, Y., Qiu, S., Chaganty, B. K. R., Zhang, L., Wang, X., Li, Q., & Fan, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.020 · Cited by 100
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
Du, T., Sikora, M. J., Levine, K. M., Tasdemir, N., Riggins, R. B., Wendell, S. G., Houten, B. V., & Oesterreich, S. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1041-8 · Cited by 99
Zhao, J., Zhang, X., Gao, T. X., Wang, S., Hou, Y., Yuan, P., Yang, Y., Yang, T., Xing, J., Li, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2221-x · Cited by 99
Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat
Matsushita, Y., Nakagawa, H., & Koike, K. (2021) · Cancers · doi:10.3390/cancers13030474 · Cited by 102
Chen, J., Chen, J., Huang, J., Li, Z., Gong, Y., Zou, B., Liu, X., Ding, L., Li, P., Zhu, Z., et al. (2019) · Aging · doi:10.18632/aging.102488 · Cited by 98
Zhang, C., Zeng, Y., Guo, X., Shen, H., Zhang, J., Wang, K., Ji, M., & Huang, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.923737 · Cited by 101
Liu, M., Quek, L., Sultani, G., & Turner, N. A. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0160-x · Cited by 100
A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment
Bamji, S. F., van Berkel, V. H., Miller, D. M., & Frieboes, H. B. (2018) · Metabolomics · doi:10.1007/s11306-018-1376-2 · Cited by 97
Dual Effects of Lipid Metabolism on Osteoblast Function
Alekos, N. S., Moorer, M. C., & Riddle, R. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.578194 · Cited by 101
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage
Kou, Y., Geng, F., & Guo, D. (2022) · Biomedicines · doi:10.3390/biomedicines10081943 · Cited by 98
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 97
Deep-lipidotyping by mass spectrometry: recent technical advances and applications
Zhang, W., Jian, R., Zhao, J. C., Liu, Y., & Xia, Y. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100219 · Cited by 99
p53 as a Regulator of Lipid Metabolism in Cancer
Parrales, A., & Iwakuma, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122074 · Cited by 97
Lo, A. K., Lung, R. W. M., Dawson, W. O., Young, L. S., Ko, C., Yeung, W. W., Kang, W., To, K., & Lo, K. W. (2018) · The Journal of Pathology · doi:10.1002/path.5130 · Cited by 95
Fatty acid oxidation and photoreceptor metabolic needs
Fu, Z., Kern, T. S., Hellström, A., & Smith, L. E. H. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000618 · Cited by 98
Hou, J. W., Jiang, C., Wen, X., Li, C., Xiong, S., Yue, T., Long, P., Shi, J., & Zhang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.949863 · Cited by 100
Hu, H., Guo, L., Overholser, J. P., & Wang, X. (2022) · Cells · doi:10.3390/cells11193174 · Cited by 100
GLP-1/GLP-1R signaling in regulation of adipocyte differentiation and lipogenesis
Chen, J., Zhao, H., Ma, X., Zhang, Y., Lu, S., Wang, Y., Zong, C., Qin, D., Wang, Y., Yingfeng Yang, Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000478872 · Cited by 94
Proteasome-associated deubiquitinases and cancer
Mofers, A., Pellegrini, P., Linder, S. T., & D’Arcy, P. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9697-6 · Cited by 101
Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review
Fakhri, S., Moradi, S. Z., Farzaei, M. H., & Bishayee, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.007 · Cited by 97
Lipids in regulating oligodendrocyte structure and function
Montani, L. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.07.016 · Cited by 99
Fazolini, N. P. B., Cruz, A. L. S., Werneck, M. B. F., Viola, J. P. B., Maya‐Monteiro, C. M., & Bozza, P. T. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1041684 · Cited by 99
Metabolic features of macrophages in inflammatory diseases and cancer
Na, Y. R., Je, S., & Seok, S. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.044 · Cited by 96
Ni, T., He, Z., Dai, Y., Yao, J., Guo, Q., & Wei, L. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.261 · Cited by 93
Dysregulated Fatty Acid Metabolism in Hepatocellular Carcinoma
Wang, M.-D., Han, J. S., Xing, H., Zhang, H., Li, Z., Liang, L., Li, C., Dai, S., Wu, M., Shen, F., et al. (2016) · Hepatic Oncology · doi:10.2217/hep-2016-0012 · Cited by 95
FASN activity is important for the initial stages of the induction of senescence
Fafián‐Labora, J., Carpintero-Fernández, P., Jordan, S. J. D., Shikh-Bahaei, T., Abdullah, S. M., Mahenthiran, M., Rodríguez‐Navarro, J. A., Niklison-Chirou, M. V., & O’Loghlen, A. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1550-0 · Cited by 91
Mitochondrial Dysfunction in the Transition from NASH to HCC
Léveillé, M., & Estall, J. L. (2019) · Metabolites · doi:10.3390/metabo9100233 · Cited by 94
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Ma, M., Zhang, Y., Pu, K., & Tang, W. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00679h · Cited by 100
Wiśniewski, J. R., Duś‐Szachniewicz, K., Ostasiewicz, P., Ziolkowski, P. P., Rakus, D., & Mann, M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00523 · Cited by 94
Clinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 99
Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics
Marković, M., Ben‐Shabat, S., Aponick, A. A., Zimmermann, E. M., & Dahan, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093248 · Cited by 91
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD
Pang, W., & Hu, F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15255 · Cited by 95
Tang, Y., Tian, W., Xie, J., Zou, Y., Wang, Z., Li, N., Zeng, Y., Wu, L., Zhang, Y., Wu, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843515 · Cited by 91
Patil, V. S., Pal, J., & Somasundaram, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6171 · Cited by 92
LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases
Zhang, Y., Meng, Q., Sun, Q., Xu, Z., Zhou, H., & Wang, Y. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101131 · Cited by 91
Elmallah, M. I. Y., Ortega‐Deballon, P., Hermite, L., de Barros, J.-P. P., Gobbo, J., & Garrido, C. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13223 · Cited by 90
Photochemical Tagging for Quantitation of Unsaturated Fatty Acids by Mass Spectrometry
Ma, X., Zhao, X., Li, J., Zhang, W., Cheng, J., Ouyang, Z., & Xia, Y. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02834 · Cited by 89
Secreted phospholipases A2 in cancer: Diverse mechanisms of action
Brglez, V., Lambeau, G., & Petan, T. (2014) · Biochimie · doi:10.1016/j.biochi.2014.09.023 · Cited by 89
Liu, P.-P., Liu, J., Jiang, W.-Q., Carew, J. S., Ogasawara, M. A., Pelicano, H., Croce, C. M., Estrov, Z., Xu, R., Keating, M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.103 · Cited by 92
Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications
Yoon, H., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042170 · Cited by 92
Raimondo, S., Saieva, L., Cristaldi, M., Monteleone, F., Fontana, S., & Alessandro, R. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.11.017 · Cited by 87
Li, Y., Kasim, V., Yan, X., Li, L., Meliala, I. T. S., Huang, C., Li, Z., Lei, K., Song, G., Zheng, X., et al. (2019) · Theranostics · doi:10.7150/thno.34931 · Cited by 89
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy
Ding, C., Shan, Z., Li, M., Chen, H., Li, X., & Jin, Z. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.02.010 · Cited by 86
Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation
Tan, W. H., Jiang, P., Zhang, W., Hu, Z., Lin, S., Chen, L., Li, Y., Peng, C., Li, Z., Sun, A., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.02.009 · Cited by 86
Wang, X., Yu, H., Gao, R., Liu, M., & Xie, W. (2023) · European journal of medical research · doi:10.1186/s40001-023-01523-7 · Cited by 87
Lopes‐Coelho, F., André, S., Félix, A., & Serpa, J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.031 · Cited by 87
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma
Buechler, C., & Aslanidis, C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158658 · Cited by 86
Obesity and prostate cancer — microenvironmental roles of adipose tissue
Saha, A., Kolonin, M. G., & DiGiovanni, J. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00764-9 · Cited by 88
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Wu, H., Fu, M., Wu, M., Cao, Z., Zhang, Q., & Liu, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06930-0 · Cited by 97
Wan, M., Pan, S., Shan, B., Diao, H., Jin, H., Wang, Z., Wang, W., Han, S., Liu, W., He, J., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02258-1 · Cited by 102
Targeting fatty acid metabolism in cancer and endothelial cells
Harjes, U., Kalucka, J. M., & Carmeliet, P. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.011 · Cited by 87
A C9orf72–CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stressPreprint
Liu, Y., Wang, T., Ji, Y. J., Johnson, K., Liu, H., Johnson, K., Bailey, S., Suk, Y., Lu, Y., Liu, M., et al. (2018) · Genes & Development · doi:10.1101/gad.315564.118 · Cited by 84
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer
Balaban, S., Nassar, Z. D., Zhang, A. Y., Hosseini-Beheshti, E., Centenera, M. M., Schreuder, M., Lin, H.-M., Aishah, A., Varney, B., Liu-Fu, F., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0347 · Cited by 82
The emerging role of targeting cancer metabolism for cancer therapy
Farhadi, P., Yarani, R., Dokaneheifard, S., & Mansouri, K. (2020) · Tumor Biology · doi:10.1177/1010428320965284 · Cited by 86
Systems biology of oxygen homeostasis
Samanta, D., Prabhakar, N. R., & Semenza, G. L. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1382 · Cited by 85
Guo, W., Tan, F., Huai, Q., Wang, Z., Shao, F., Zhang, G., Yang, Z., Li, R., Xue, Q., Gao, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669750 · Cited by 84
Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
Han, J., Li, Q., Chen, Y., & Yang, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.763902 · Cited by 90
Serum Metabolomic Signatures of Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma
Jin, H. D., Qiao, F., Chen, L., Lu, C., Xu, L., & Gao, X. (2014) · Journal of Proteome Research · doi:10.1021/pr500483z · Cited by 84
Crooks, D. R., Maio, N., Lang, M., Ricketts, C. J., Vocke, C. D., Gurram, S., Turan, S., Kim, Y., Cawthon, G. M., Sohelian, F., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc4436 · Cited by 87
Shah, S., Carriveau, W. J., Li, J., Campbell, S. L., Kopinski, P. K., Lim, H., Daurio, N. A., Trefely, S., Won, K., Wallace, D. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9666 · Cited by 85
Moulder, D. E., Hatoum, D., Tay, E. S. E., Lin, Y., & McGowan, E. M. (2018) · Cancers · doi:10.3390/cancers10060189 · Cited by 87
Sahlberg, S. H., Mortensen, A. C. L., Haglöf, J., Engskog, M. K. R., Arvidsson, T., Pettersson, C. E., Glimelius, B. L. G., Stenerlöw, B., & Nestor, M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3771 · Cited by 85
Metadata
- Authors
- Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V.
- Affiliations
- University of California, San Francisco (US)
- Cancer Research UK (GB)
- University of Graz (AT)
- Yale University (US)
- Corresponding author
- Farese, Robert V.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 18
- Issue
- 2
- Pages
- 153-161
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3742569
- OpenAlex
- W1980568044
- Cited by
- 2,123
- References
- 82
- Citations by year
- 2026: 118 · 2025: 221 · 2024: 228 · 2023: 221 · 2022: 266 · 2021: 204 · 2020: 193 · 2019: 177 · 2018: 139 · 2017: 122 · 2016: 115 · 2015: 72 · 2014: 41 · 2013: 1
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 370 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM099844, R01GM097194)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056084, P30DK063720, P30DK026743)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- fatty acid metabolism, cancer metabolism, lipid metabolism, tumor cell proliferation, fatty acid availability, membrane lipid synthesis
- MeSH terms
- Energy Metabolism, Fatty Acids, Humans, Neoplasms, Cell Proliferation, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
